A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma

Clinical trial NCT04356729 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04356729
Sponsor: F. Stephen Hodi, MD
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Clinical Stage III Cutaneous Melanoma AJCC v8 Stage IV Melanoma Unresectable Stage III Cutaneous Melanoma Unresectable Stage IV Cutaneous Melanoma

Start date: 2020-08-06
Primary completion: 2026-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.